MG MED Inc.

MG MED Inc.
Stock Exchange Korea Exchange
EPS
KRW269.33
Market Cap
KRW180.76 B
Shares Outstanding
18.89 M
Public Float
14.58 M

Profile

Address
Unit 1003, Elysia Building
Seoul SL 08511
Korea, Republic Of
Employees -
Website http://www.cancerrop.com
Updated 09/14/2018
Cancer Rop Co., Ltd. engages in the development of molecular diagnostic products. It operates through Molecular Diagnostics and Bio-Reagents Business divisions. The molecular diagnostic business division provides deoxyribonucleic acid (DNA) chips and polymerase chain reaction(PCR) kits.

Financials

View All
Created with Highcharts 5.0.14MG MED Inc.Net Income. Fiscal year is January-December. All values KRW Millions.2552552082086156154804802 1782 1782013201420152016201705001000150020002500
Created with Highcharts 5.0.14MG MED Inc.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.3 8753 8754 6914 6915 3875 3875 0985 0984 6704 6702013201420152016201701k2k3k4k5k6k

Jang-Woo Lee
Chief Executive Officer & Director
Yeon-Mok Oh
Non-Executive Director